Pharm 101: Metoprolol

Class

Beta-Blocker

Pharmacodynamics
  • Along with bisoprolol, atenolol, nebivolol, esmolol, act via selective B1-receptor blockade
    • Equally selective to B1 blockade as propranolol
    • However, 50-100x less potent than propranolol in blocking B2-receptors
    • At higher doses, metoprolol is less selective in blockade
  • Cardiovascular effects:
    • Negative inotrope and chronotrope
    • Slows AV conduction (prolongs PR interval)
    • Suppresses renin release mediated via beta-receptors through catecholamines (decreases blood pressure)
Pharmacokinetics
  • PO or IV administration
  • Well absorbed orally but bioavailability 50% due to high first pas metabolism
  • Hepatic metabolism
  • Large volume of distribution (> 200L)
  • Moderate lipid solubility
  • Half-life 3-4 hours
Clinical uses
  • Hypertension
  • IHD (reduced frequency of anginal episodes and improved exercise tolerance)
  • Improved survival after MI
  • Arrhythmias: AF / flutter
  • CCF
Adverse effects
  • Bradycardia
  • Hypotension
  • Bronchoconstriction (although less common with selective B1-blockade)
  • Vivid dreams
Further Reading
Pharm 101 700

Pharmacology 101

Top 200 drugs

MBBS (UWA) CCPU (RCE, Biliary, DVT, E-FAST, AAA) Emergency Medicine Advanced Trainee in Melbourne, Australia. Special interests in diagnostic and procedural ultrasound, medical education, and ECG interpretation. Editor-in-chief of the LITFL ECG Library. Twitter: @rob_buttner

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.